Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/4/2025

Eperisone for Lumbar Pain Management

Guideline-Based Treatment Hierarchy

  • NSAIDs are the preferred initial medication for acute low back pain, providing small to moderate improvements in pain intensity, according to the American College of Physicians 1
  • Acetaminophen serves as an alternative first-line option due to favorable safety profile, though evidence shows no significant difference from placebo, as stated by the American College of Physicians 1
  • Patients should remain active and avoid bed rest, as activity restriction prolongs recovery, recommended by the American College of Physicians 1

Second-Line Therapy: Skeletal Muscle Relaxants

  • Skeletal muscle relaxants (as a class) are moderately superior to placebo for short-term pain relief in acute low back pain, with relative risks for not achieving pain relief of 0.80 (CI, 0.71 to 0.89) at 2-4 days, according to the American College of Physicians 2, 3
  • Major guidelines found insufficient evidence to conclude that any specific muscle relaxant is superior to others for benefits or harms, as reported by the American College of Physicians 2, 3
  • All skeletal muscle relaxants carry central nervous system adverse effects, primarily sedation, warned by the American College of Physicians 1

Clinical Decision Algorithm

  • For acute low back pain, start with NSAIDs (lowest effective dose, shortest duration) + activity maintenance, recommended by the American College of Physicians 1
  • If NSAIDs contraindicated or insufficient after 2-4 days, add skeletal muscle relaxant, suggested by the American College of Physicians 2, 1

Chronic Low Back Pain Management

  • Evidence for skeletal muscle relaxants (including eperisone) in chronic low back pain is sparse and of lower quality, reported by the American College of Physicians 2, 3
  • Only one lower-quality trial evaluated a muscle relaxant for chronic low back pain in the major guideline review, noted by the American College of Physicians 2

What NOT to Do

  • Do not use eperisone as first-line therapy before trying NSAIDs or acetaminophen, advised by the American College of Physicians 1
  • Do not prescribe extended courses without clear evidence of continued benefits, warned by the American College of Physicians 1
  • Avoid combining with benzodiazepines, which carry abuse and addiction risks, cautioned by the American College of Physicians 1